| Cancer drug delivery in the nano era: An overview and perspectives Z Li, S Tan, S Li, Q Shen, K Wang Oncology reports 38 (2), 611-624, 2017 | 452 | 2017 |
| Transcription factor STAT3 as a novel molecular target for cancer prevention A Xiong, Z Yang, Y Shen, J Zhou, Q Shen Cancers 6 (2), 926-957, 2014 | 325 | 2014 |
| The role of STAT3 in leading the crosstalk between human cancers and the immune system Y Wang, Y Shen, S Wang, Q Shen, X Zhou Cancer letters 415, 117-128, 2018 | 322 | 2018 |
| Small molecule inhibitors targeting activator protein 1 (AP-1) miniperspective N Ye, Y Ding, C Wild, Q Shen, J Zhou Journal of medicinal chemistry 57 (16), 6930-6948, 2014 | 284 | 2014 |
| Discovery and development of natural product oridonin-inspired anticancer agents Y Ding, C Ding, N Ye, Z Liu, EA Wold, H Chen, C Wild, Q Shen, J Zhou European journal of medicinal chemistry 122, 102-117, 2016 | 179 | 2016 |
| TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway X Meng, C Cai, J Wu, S Cai, C Ye, H Chen, Z Yang, H Zeng, Q Shen, ... Cancer letters 333 (1), 96-102, 2013 | 170 | 2013 |
| The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors Q Shen, IP Uray, Y Li, TI Krisko, TE Strecker, HT Kim, PH Brown Oncogene 27 (3), 366-377, 2008 | 166 | 2008 |
| Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide L Lu, J Dong, L Wang, Q Xia, D Zhang, H Kim, T Yin, S Fan, Q Shen Oncogene 37 (39), 5292-5304, 2018 | 155 | 2018 |
| Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade Z Zhang, Q Duan, H Zhao, T Liu, H Wu, Q Shen, C Wang, T Yin Cancer letters 382 (1), 53-63, 2016 | 155 | 2016 |
| Up‐regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine‐resistant pancreatic cancer cells H Zhao, Q Duan, Z Zhang, H Li, H Wu, Q Shen, C Wang, T Yin Journal of cellular and molecular medicine 21 (9), 2055-2067, 2017 | 153 | 2017 |
| Effect of cadmium on oxidative stress and immune function of common carp (Cyprinus carpio L.) by transcriptome analysis Z Zhang, Z Zheng, J Cai, Q Liu, J Yang, Y Gong, M Wu, Q Shen, S Xu Aquatic Toxicology 192, 171-177, 2017 | 144 | 2017 |
| Discovery of O-Alkylamino-Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents H Chen, Z Yang, C Ding, L Chu, Y Zhang, K Terry, H Liu, Q Shen, J Zhou ACS medicinal chemistry letters 4 (2), 180-185, 2013 | 138 | 2013 |
| Humanized NOD-SCID IL2rg–/–mice as a preclinical model for cancer research and its potential use for individualized cancer therapies Q Zhou, J Facciponte, M Jin, Q Shen, Q Lin Cancer letters 344 (1), 13-19, 2014 | 129 | 2014 |
| Downregulation of ACE2/Ang-(1–7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry C Yu, W Tang, Y Wang, Q Shen, B Wang, C Cai, X Meng, F Zou Cancer letters 376 (2), 268-277, 2016 | 127 | 2016 |
| Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway J Han, B Han, X Wu, J Hao, X Dong, Q Shen, H Pang Toxicology and applied pharmacology 359, 55-61, 2018 | 125 | 2018 |
| Mitochondrial Ca2+ uniporter is critical for store-operated Ca2+ entry-dependent breast cancer cell migration S Tang, X Wang, Q Shen, X Yang, C Yu, C Cai, G Cai, X Meng, F Zou Biochemical and biophysical research communications 458 (1), 186-193, 2015 | 124 | 2015 |
| cFos is critical for MCF-7 breast cancer cell growth C Lu, Q Shen, E DuPre, H Kim, S Hilsenbeck, PH Brown Oncogene 24 (43), 6516-6524, 2005 | 115 | 2005 |
| Therapeutic potential of oridonin and its analogs: from anticancer and antiinflammation to neuroprotection J Xu, EA Wold, Y Ding, Q Shen, J Zhou Molecules 23 (2), 474, 2018 | 113 | 2018 |
| Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility C Ding, Y Zhang, H Chen, Z Yang, C Wild, L Chu, H Liu, Q Shen, J Zhou Journal of medicinal chemistry 56 (12), 5048-5058, 2013 | 112 | 2013 |
| Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy H Chen, Z Yang, C Ding, L Chu, Y Zhang, K Terry, H Liu, Q Shen, J Zhou European journal of medicinal chemistry 62, 498-507, 2013 | 110 | 2013 |
